<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>BioMedGPT-Mol: Multi-task Learning for Molecular Understanding and Generation - Health AI Hub</title>
    <meta name="description" content="BioMedGPT-Mol introduces a novel molecular language model adapted from a general-purpose reasoning model through a meticulously designed multi-task learning fra">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>BioMedGPT-Mol: Multi-task Learning for Molecular Understanding and Generation</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2512.04629v1" target="_blank">2512.04629v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-12-04
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Chenyang Zuo, Siqi Fan, Zaiqing Nie
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.AI
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.95 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2512.04629v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2512.04629v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">BioMedGPT-Mol introduces a novel molecular language model adapted from a general-purpose reasoning model through a meticulously designed multi-task learning framework. Leveraging a large, curated dataset, it supports molecular understanding and generation tasks, achieving remarkable performance on various benchmarks. This work demonstrates the effective and efficient post-training of large language models for specialized applications in molecular science and drug discovery.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research significantly advances AI's role in small molecule drug development by offering a powerful tool for designing, understanding, and planning the synthesis of potential drug candidates, thereby accelerating the discovery and development of new therapeutics.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>BioMedGPT-Mol is an AI-powered molecular language model designed to accelerate small molecule drug discovery and development. It assists in understanding molecular properties and generating novel molecular structures, including capabilities for end-to-end retrosynthetic planning, which is critical for synthesizing drug candidates efficiently. This directly falls under medical AI applications for drug development.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>BioMedGPT-Mol is a specialized molecular language model (MLM) developed for molecular understanding and generation tasks.</li>
                    
                    <li>It is built upon a general-purpose reasoning model, fine-tuned using a multi-task learning framework to adapt it for molecular science applications.</li>
                    
                    <li>A large-scale, comprehensive, and high-quality training dataset was assembled by curating and unifying existing public instruction datasets.</li>
                    
                    <li>The model demonstrated remarkable performance on consolidated benchmarks including LlaSMol, TOMG-Bench, and MuMOInstruct.</li>
                    
                    <li>BioMedGPT-Mol achieved competitive capabilities as an end-to-end retrosynthetic planner, validated on RetroBench.</li>
                    
                    <li>The research validates that general-purpose reasoning models can be effectively and efficiently specialized into professional molecular language models through structured multi-task curriculum.</li>
                    
                    <li>The authors anticipate the approach can be extended to other biomedical scientific domains.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The methodology involved curating and unifying existing public instruction datasets to create a large-scale, high-quality training dataset. An existing general-purpose reasoning model was then fine-tuned using a meticulously designed multi-task learning framework. Performance was evaluated on a consolidated benchmark derived from LlaSMol, TOMG-Bench, and MuMOInstruct, and further assessed for retrosynthetic planning on RetroBench.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>BioMedGPT-Mol achieves remarkable performance in molecular understanding and generation tasks, validating the efficacy of fine-tuning a general-purpose reasoning model into a specialized molecular language model. It demonstrates competitive capability as an end-to-end retrosynthetic planner, showcasing its practical utility in complex chemical synthesis planning. This work proves that a well-structured multi-task curriculum can efficiently post-train LLMs for professional scientific applications.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>By providing advanced capabilities for molecular design and retrosynthetic planning, BioMedGPT-Mol can significantly accelerate the early stages of drug discovery and development. It could lead to the faster identification of novel drug candidates, optimize synthetic routes for potential therapeutics, and ultimately reduce the time and cost associated with bringing new medicines to market.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state any limitations of the BioMedGPT-Mol model or the multi-task learning framework.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The authors anticipate that their multi-task learning approach for specializing general-purpose reasoning models can be extended and applied to other biomedical scientific domains beyond molecular understanding and generation.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Medicinal Chemistry</span>
                    
                    <span class="tag">Pharmacology</span>
                    
                    <span class="tag">Drug Discovery and Development</span>
                    
                    <span class="tag">Chemical Biology</span>
                    
                    <span class="tag">Pharmaceutical Sciences</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">molecular language model</span>
                    
                    <span class="tag tag-keyword">drug discovery</span>
                    
                    <span class="tag tag-keyword">multi-task learning</span>
                    
                    <span class="tag tag-keyword">retrosynthesis</span>
                    
                    <span class="tag tag-keyword">molecular generation</span>
                    
                    <span class="tag tag-keyword">biomedical AI</span>
                    
                    <span class="tag tag-keyword">small molecules</span>
                    
                    <span class="tag tag-keyword">pharmaceutical research</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Molecules play a crucial role in biomedical research and discovery, particularly in the field of small molecule drug development. Given the rapid advancements in large language models, especially the recent emergence of reasoning models, it is natural to explore how a general-purpose language model can be efficiently adapted for molecular science applications. In this work, we introduce BioMedGPT-Mol, a molecular language model designed to support molecular understanding and generation tasks. By curating and unifying existing public instruction datasets, we have assembled a large-scale, comprehensive, and high-quality training dataset. The model is then fine-tuned through a meticulously designed multi-task learning framework. On a consolidated benchmark derived from LlaSMol, TOMG-Bench, and MuMOInstruct, BioMedGPT-Mol achieves remarkable performance. Our experimental results demonstrate that a general-purpose reasoning model can be effectively and efficiently post-trained into a professional molecular language model through a well-structured multi-task curriculum. Leveraging the power of it, we further explore retrosynthetic planning task, and the performance on RetroBench demonstrates its competitive capability of acting as an end-to-end retrosynthetic planner. We anticipate that our approach can be extended to other biomedical scientific domains.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>